This article showcases our top picks for the best London based Biotechnology companies. These startups and companies are taking a variety of approaches to innovating the Biotechnology industry, but are all exceptional companies well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups and companies for exceptional performance in one of these categories:
- Innovative ideas
- Innovative route to market
- Innovative product
- Exceptional growth
- Exceptional growth strategy
- Societal impact
Top London Biotechnology Companies
GlaxoSmithKline is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. The company aims to bring differentiated, high-quality and needed healthcare products to as many people as possible, with its 3 global businesses, scientific and technical know-how, and talented people.
GSK’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in respiratory and HIV. Our R&D approach focuses on science related to the immune system, the use of genetics, and advanced technologies.
The Vaccines business has a broad portfolio and innovative pipeline of vaccines to help protect people throughout life. It delivers over two million vaccine doses per day to people living in over 160 countries.
The Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert-recommended brands in the Pain relief, Respiratory, Digestive health, Oral Health, Nutrition, and Skin health categories.. Determined to steer the growth of the AR industry and champion this new consumer behavior, Blippar acquired Layar in June 2014, a pioneering AR company founded in the late 2000s.
In June 2015, Blippar invested in smart specs company WaveOptics. WaveOptics is developing low-energy lenses that provide a live display for the wearer but can be fitted into ordinary spectacles frames..
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science.
It was founded in 1936 and headquartered in London, England.. As well as being listed as top 50 digital agency by Econsultancy in 2016, Fetch has also been named mobile agency of the year in three consecutive years, and was voted fastest growing mobile marketing agency in Europe by Media Momentum Awards..
Last November, Prime Minister Theresa May and the Chancellor Philip Hammond announced the launch of Tech Nation, consolidating Tech City UK and Tech North’s impact. Now as Tech Nation, we’re expanding our network of growth programmes, events, skills and data resources to reach all corners and clusters of the UK.
What we do continues to be shaped by your voices. We just finished a listening tour to meet representatives from the UK’s vibrant tech landscape and understand how best to shape our national network to meet your challenges..
Arix Bioscience is a global healthcare and life science company that drives value in private and public companies through operational and strategic direction as well as patient capital Their extensive experience in academic science, clinical and commercial strategy, company operations, mergers and acquisitions, venture capital and corporate finance puts them in an especially strong position to build and support a wide range of businesses and technologies. Arix Bioscience has privileged agreements with leading universities in the UK, Europe and Australia, providing direct access to innovative new technologies.
They also have access to a broad range of research projects from US academic institutions.. .
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. The company’s immunotherapies harness the immune system to destroy cancer cells that target truncal tumor neo-antigens and flags to the immune system present on the surface of every cancer cell, enabling scientists to target and destroy tumors without harming healthy tissues..
Uniquely, the platform encourages collaborative learning by offering users the unique opportunity to learn the language and practice their listening, writing, reading and speaking with assistance from a rapidly growing community of native speakers. In this way, every busuu user is both student of a foreign language and tutor of their own ‘mother tongue’.
busuu was founded by Bernhard Niesner and Adrian Hilti in early 2008, with a vision to enable everyone in the world to learn a second language. Based in London, busuu offers an integrated, cross-channel platform which is constantly evolving to meet the demands of an increasingly mobile world population.
Winner of ‘Best Education Start‐up’ at The Europas TechCrunch Awards in 2011 and CeBIT Innovation Award in 2010. The company now also offers corporate language training solutions for large international companies around the world.
The company is named after the busuu language of Cameroon. According to an ethnological study from the 1980s, Busuu is spoken by only 8 people..
Huma is a global health tech company with a mission to help people with chronic, complex, and rare diseases to live longer, better lives. Huma works with world-leading healthcare providers, pharmaceutical, insurance and technology companies, including Apple and Tencent, to build a connected digital health ecosystem.
Headquartered in London, Medopad has offices in the US and China.. Graduway’s SaaS platform will be ready to use within minutes, available on all devices, easy to manage and will offer alumni exclusive benefits, mentoring tools and unique career opportunities..
BenevolentAI unites technology with human intelligence to re-engineer drug discovery and deliver life-changing medicines. We have developed the Benevolent Platform®, a drug discovery platform built on powerful data foundations with state of the art machine learning and AI technology.
Our technology empowers scientists to decipher the vast and complex code underlying human biology, find new ways to treat disease and personalise medicines to patients. Benevolent has active in-house R&D drug programmes in disease areas such as neurodegeneration, immunology, oncology and inflammation and has research and commercial collaborations with leading pharmaceutical and research organisations.
The company is headquartered in London with a research facility in Cambridge (UK) and a further office in New York.. .
Autolus is in T-cell programming and manufacturing technology and believes its leadership will provide a competitive advantage as it looks to develop future generations of T cell therapies targeting both hematological cancers and solid tumors. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer.
The company’s pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and others.. This is enhanced by third party data partnerships, which enable LoopMe to access data including credit card purchases, car registrations, loyalty card and TV viewership in-flight.
Real-time AI optimization uses this data to optimize media performance to users delivering on brand outcomes, while transparent analytics provides clients with deep insights into their active audience.. .
EMMAC Life Sciences
EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation, extraction, and production. It has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also as a European leader in the production and supply of medical cannabis, hemp, and other derivatives products.
It was founded in 2018 and is headquartered in London, England.. .
Orchard Therapeutics is a leading global fully integrated commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies. Orchard’s portfolio of autologous ex vivo gene therapy programs has demonstrated sustained clinical benefit in over 150 patients across five disease areas.
These programs include Strimvelis®, the first autologous ex vivo gene therapy approved by the EMA in 2016, 3 programs in advanced registrational studies in MLD (metachromatic leukodystrophy), WAS (Wiskott Aldrich syndrome) and ADA-SCID (adenosine deaminase severe combined immunodeficiency), 2 other clinical programs in X-CGD (X-linked chronic granulomatous disease) and beta-thalassemia, as well as an extensive preclinical pipeline. The company is partnered with world-leading institutions in gene therapy, including University College London, Great Ormond Street Hospital, the University of Manchester and Central Manchester University Hospitals, the University of California Los Angeles and Boston Children’s Hospital, and Telethon Institute of Gene Therapy/Ospedale San Raffaele.
Orchard is a publicly traded company (NASDAQ: ORTX) with offices in the UK and the US, including London, San Francisco and Boston.. Our team members, investors and advisors come from the Media & Entertainment industry and together we are executing an ambitious plan to scale globally.
This is a great opportunity to join our team of 85 employees at a key stage in the company’s life as we expand internationally.. .
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. Its protein engineering platform integrates several bleeding-edge technologies from the fields of machine learning, synthetic biology, and robotics..
SuperAwesome was founded in 2013 and is headquartered in London.. .
Synthace’s goal is to raise universal bioscience productivity, enabling people to better engineer biology for health, food, energy and manufacturing. Central to its technology is Antha, an operating system for biology that enables ease of designing and optimizing biological unit operations that are linked into executable workflows that are reliable, shareable and saleable.
Antha spreads biological information in a repeatable way, linking lab equipment, protocols and processes, thereby allowing vast and speedy development, enhancing productivity for any bioscience.. Among a range of leading data products available alongside its flagship survey are its B2B data set, GWI Work, which analyzes professionals across 10 global markets, and its TV reach and frequency solution, which enables advertisers to target previously untapped audiences.
Its newest data set launched in July 2020, GWI USA, responded to the increasing demand for more relevant and timely insight into the modern American consumer. Representing over 240 million people across all 50 states, the study tracks new and emerging trends not typically covered by traditional market research providers, including key questions around cultural identity, race and ethnicity..
At the same time quality has been maintained, with 70,000+ 5* reviews and every tutor personally interviewed. MyTutor was founded by Robert Grabiner, Bertie Hubbard and James Grant..
Lifebit CloudOS is an intelligent genomics platform that understands DNA data and generates meaningful insights like humans do. This offers researchers, and their organisations (ie.
top tier pharmas), a highly scalable, modular and reproducible system that automates the analysis processes, learns from the data via AI and provides actionable insights.. .
This enables more effective planning, activation and measurement for marketers and business decision makers alike, fuelling the next generation of insight-driven marketing. With 33 offices across five continents, Blis works with the world’s largest and most customer-driven companies across all verticals including Unilever, Samsung, McDonald’s, HSBC, Mercedes Benz and Peugeot, as well as every major media agency to reach over a billion mobile devices a year..
Entocycle is developing the world’s most efficient and sustainable way to produce protein. The rainforests and savannahs of South America are being destroyed at shocking rates in order to grow crops such as soy to feed farm animals.
Using insects to feed livestock requires significantly less land and water compared to soy whilst being a natural part of the diet for many animals including fish, chickens and pigs. Their technology is significantly more efficient at producing protein than traditional methods of production as their insects are vertically farmed and not restricted to floor space or area.
Thanks to their automated system they can produce at industrial scale and offer farmers a cost-effective and sustainable alternative to soymeal and fishmeal.. It’s time to know more in no time.
It was founded in 2019 and is headquartered in London, England.. .
Peptone is a UK-based startup that is helping pharmaceutical companies unravel the secrets of proteins. We teach AI machines protein physics so that they can reason with protein data just like human researchers do, and design experimentally testable hypotheses..
Nominated for a 2019 Emmy Award, Winner Kidscreen Best Learning App Award, Winner of multiple Parents’ Choice awards, Apple Best of Awards, and 2019 Rockie Award.. .
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products.
The Company’s technology harnesses the body’s natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types..
Mereo is based in London and was founded in March 2015 to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies. Pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs.
With significant P&L constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates, especially beyond Phase 2. Mereo has been formed to take advantage of the global pharmaceutical industry’s drive for creative ways to progress their clinical development pipelines.
Mereo has acquired an initial mid-late stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from Novartis Pharmaceuticals. Each of these programmes has a comprehensive dataset for both pre-clinical and proof-of-concept clinical studies.
Additional product opportunities are under evaluation. Mereo’s focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world.
To do this, the Company depends on the combination of its team’s expertise in selecting and acquiring product opportunities, creating value in the development pipeline and structuring creative transactions. Mereo’s internal expertise is complemented by a unique partnership with a leading global CRO, ICON.
Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products.
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect, so that breakthroughs happen faster.
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK..
Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. The company is focused on the natural power of the body to cure disease.
Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action. Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders..
Their words are carefully selected and curated by Cambridge University data scientists to ensure that children learn the words they will come across at school and in the books they read. Loved by teachers, parents and students..
Myovant Sciences is to deliver innovative women’s health and prostate cancer solutions by efficiently advancing new medicines to market.. .
This innovative product gives advertisers the ability to harness the accuracy of search and combine it with the high impact and scalable nature of display advertising. Captify are currently the largest holders of Keyword Search Data in Europe, providing in depth granularity for campaign optimization and reporting..
They have sparked the imaginations of kids in over 87 countries around the world. They work closely with children to design their kits, engaging in large scale research projects before beginning on design & manufacture..
Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering.
In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.. Founded in 2014 by Harvard graduates set on building something amazing and worthwhile, UENI is now made up of over 60 people working to shift the balance between independent businesses and larger franchises.
We believe that customers should have more choice and transparency, and we’re helping small businesses to provide it. From service providers like dentists and plumbers to photographers or restaurant owners, our mission is to make all businesses visible online.
UENI now builds thousands of new sites every day, across 9 countries and 70 cities – and we’re just getting started.. .
Polymateria is a London-based startup advancing science to help nature deal with plastic pollution. The company is developing a new standard in biodegradable and compostable plastics.
Its new technology, called Biotransformation, fully biodegrades common forms of plastic, leaving behind zero microplastics with no environmental harm in the process. The new technology is ensuring that plastic which has escaped refuse streams can fully biodegrade in the natural environment.
Polymateria’s Cycle+ brings advanced biodegradation technology to different types of plastic, without affecting its recyclability within the product’s useful life. The company DegrAid product is designed specifically for the end of life situations where recycling is not an option, e.g sealant films.
Polymateria was founded in 2016 and is headquartered in London, England, UK.. .
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing.
The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.. Mirriad currently operates in the US, Europe and China..
They believe that enabling schools to provide smart, modern university and careers guidance is a matter of huge importance. Partnering with schools in over 60 countries, BridgeU empowers schools to prepare the students of today for the world of tomorrow..
Skipping Rocks Lab
Skipping Rocks Lab is a London-based startup that develops natural and biodegradable packaging for liquids made from seaweed extract. It has developed Ooho!, an edible water bottle alternative to plastic bottles.
Skipping Rocks Lab was co-founded by graduates from Imperial College and Royal College of Art and is currently incubated in the Climate KIC accelerator.. For childcare providers, this means allowing them to focus on the children in their care, relieving the burden of running a small business and ensuring maximum job satisfaction..
Eleusis is a clinical stage life science company dedicated to unlocking the therapeutic potential of serotonin 2A receptor agonists, commonly referred to as psychedelics, through the mitigation and management of psychoactivity. Outside of North America, Base79 is YouTube’s largest partner and Multi-channel Network.
The company manage over 800 YouTube channels and work with 400 premium content partners including BBC Worldwide, Endemol’s Tiger Aspect, IMG Media, Ministry of Sound, Guinness World Records and a growing base of YouTube content creators. The company generate 650M views a month on YouTube.
As an independent company, Base79’s unique technology and media relationships create a generation of new and safe revenue opportunities for its partners. Base79 have specialist advertising sales teams, working with global brands to create targeted and innovative ways to engage with video content and communities on the web.
Established in 2007 the company began as ‘My Video Rights’, and were leaders in online Rights Management and multi-platform video distribution and monetization. The company have offices in London, Los Angeles, Madrid, Paris, Berlin and Sydney, and plans further expansion in 2013.
The team at Base79 are YouTube Certified, and received five original programming grants from YouTube to become their largest original content providers.. .
Desktop Genetics is an international biotechnology company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology.
They have invested four years developing their core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers their flagship DESKGEN CRISPR Library product range, which enables the work of their pharma, biotech and academic customers working in drug discovery and functional genomics.
Desktop Genetics’ tools and technologies are used by over 1800 organisations all over the world, and their projects contribute directly to several key partnerships to bring CRISPR into the clinic. The company has received awards from Fast Company, Kairos 50 and SxSW Interactive..
Annual ecommerce transactions in Skimlinks’ network totalled $1 billion in 2017. Clients include over half of the top 100 US & UK publishers by revenue including Conde Nast, Hearst, Buzzfeed, Huffington Post, Trinity Mirror, MailOnline, and more..
bio-bean is an award-winning green energy company that has industrialised the process of recycling waste coffee grounds into advanced biofuels. bio-bean works within the existing supply chain to collect and aggregate thousands of tonnes of waste coffee grounds produced by coffee factories, coffee shops, transport hubs and offices.
At bio-bean’s innovative factory, waste coffee grounds are recycled into biomass pellets, which are used to heat buildings. In the near future, bio-bean will also produce biodiesel at an industrial scale, which can be used to power transport systems.
bio-bean’s offering is commercial – reducing waste collection cost and eliminating waste disposal gate fees. The bio-bean process diverts waste from landfill, incineration or anaerobic digestion to reduce greenhouse gas emissions and create carbon-neutral biofuels.
bio-bean help businesses to save money, achieve sustainability goals and increase transparency of coffee waste disposal.. .
Unibio International was incorporated in 2014, and its 100% owned subsidiary company was incorporated in 2001. The concept underlying Unibio’s U-Loop technology is simple: natural gas (methane) can be converted into a highly concentrated protein product, Uniprotein®, which can be used as a direct supplement in feed for animals.
It can substitute fishmeal, a traditional feed component, and an increasingly scarce resource. The ambition of Unibio is to become the world market leader within protein production based on methanotrophic bacteria, partly by own production and partly by licensing the production technology to international investors wishing to establish large-scale production plants of Uniprotein® using the surplus gas from oil production.
Unibio is also committed to the continuous development of the U-Loop technology to improve productivity.. .
Cytera CellWorks, a biotechnology platform, builds machines that automate growing mammalian cells for biotech. Based in London, England, the company was founded by Ignacio Willats and Ali Afshar..
The platform combines different advocacy tools (including challenges, UGC, referrals, loyalty, affiliates and surveys), under one platform so brands can build rich, customer membership clubs and VIP programs with airline style ‘status’ tiers, groups and segmentation. Spun out from Daredevil Project mobile app and game studio by world-record breaking adventurer and former brand ambassador, Paul Archer, and viral games developer, Panagiotis Tsarouchis, the Duel team is made up of psychologists, brand experts and community builders from companies including Amazon and Lululemon.
Committed to working with brands that put people and the planet over profit, Duel is demystifying word-of-mouth marketing to breaking brands’ reliance on digital advertising and other short-term marketing practices to build brand movements and deliver long-term growth. The platform is used by brands such as Rab, Lowe Alpine, Monica Vinader, King of Shaves, Frugi and Mud Jeans and has consulted with over 450 brands including Amex, Travelex, M&S, Philips, Boots, Schuh and TopShop..
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The company develops life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.
Akari Therapeutics was founded in 2015 and is headquartered in London, England.. .
Supponor’s highly skilled software engineers in the research and development team in Espoo, Finland, work constantly to refine and further develop the technology underpinning DBRLive, pushing boundaries to create new value for our clients and partners. Supponor is a privately-held company, owned by management, private investors and VC funds – Sports Investment Partners, Northzone, and Conor..
Liver cirrhosis kills more than a million people a year. More than 650 million people around the world suffer from chronic liver disease, costing economies €15.8 billion annually.
Yaqrit Limited is developing a family of liver disease treatments that will transform the lives of these patients. Today, there are few options for treatment.
Antibiotics and laxatives, which target gut bacteria and bacterial products, or a liver transplant are the standards of care. The drawbacks of widespread antibiotic use are well-known, and waiting lists for transplants are long – in the UK, for example, 30% of patients on the waiting list have been there for more than two years..
EdSurge ranked Quizalize as the “No.1 new app for schools” in 2015 and Zzish was selected as one of the “Future 30” at the Bett Show (Europe’s leading EdTech trade show) and one of the “EdTech 20” at EdTechXEurope (Europe’s leading EdTech investor summit). Moreover the Zzish Teacher Dashboards was the runner up for Teach Secondary’s “Technology Innovation of the Year” and a finalist for selection in the Education Resource Awards..
Gardin develops optical phenotyping technology and analytics to optimise food production.. .
Their ads are more context aware and relevant to the listener, and so perform a lot better. They have delivered over 100 campaigns across Europe for brands including Audible, Deliveroo, Carphone Warehouse, Asda and Nissan, are working with four of the six major advertising agencies and have partnerships with Global Radio’s DAX and Pandora (the world’s largest ad-funded music streaming service)..
Puraffinity was incorporated in 2015 and is headquartered in London. The company specialises in the design of advanced materials, and has developed a bio-based novel adsorbent capable of removing highly challenging pollutants from contaminated water and wastewater.
The technology utilises advanced supramolecular chemistry methods to functionalise bio-based materials designed to bind target chemicals. The company is at the forefront of developing solutions for overcoming imminent water quality challenges, whilst sustainable and positive environmental impact lies at the heart of the company’s ethos..
The app allows fans to purchase digital fan club subscription packages on a recurring monthly or yearly basis. This in turn gives access to exclusive content, communication and feedback from artists; video blogs, pre-sale tickets and allows sale of merchandise during events for collection after the show..
FarmaTrust is the most efficient global tracking syswetem which provides security to the pharmaceutical companies, governments, regulators and the public, that counterfeit drugs do not enter the supply chain. Their Blockchain based system utilises Artificial Intelligence and big data analysis to provide the pharmaceutical industry with value added services which allow for more efficient processes and methods as well as a more transparent supply chain.
Their system is safe, secure, encrypted and immutable.. .
Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London..
TV hits include Love Island, X Factor, The Voice and Britain’s Got Talent, where Monterosa tech lies at the heart of the official show apps and interactive experiences across all screens. We help our clients provide game-changing real-time interactivity that grows active, loyal audiences directly.
We monetise their attention with commerce and first party data. Our technology is trusted by the world’s biggest media organisations and brands to deliver at extreme volumes and securely.
Audience experiences include mobile apps, web apps, social media, messaging, and augmented reality. Our creative and delivery teams are award-winning experts in interactivity with TV and sport, and we provide round the clock support to ensure creativity and innovation is matched with reliability and peace of mind..
The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, their mission is to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early stage research into commercially viable and investable therapies.
They are based on the 12th floor of Guy’s Hospital in central London, with over 120 cell and gene therapy experts, state-of-the art development and viral vector laboratories. They are also building a £55m large-scale GMP manufacturing centre to help bring cell and gene therapies to market in the UK and internationally..
LIfT BioSciences is a socially-minded Biotech start-up that develops a portfolio of potentially life-saving immuno-oncology cell therapies for different solid tumors using its innate immunity platform. Its goal is to create a Cell Bank with the potential to cure cancer, using Leukocyte Infusion Therapy.
LIfT BioSciences was founded in 2016 and headquartered in London, England.. Exit Bee works directly with the biggest brands and agencies to run unique, high-impact campaigns the moment users are most receptive.
Exit Bee creates new ad real estate at an exclusive network of publishers and provides advertisers the most premium and safe placement to reach their audience.. .
Evodental, a Huyton, UK-based provider of private dental implants. Founded in 2008 by dentist and entrepreneur Dr Rajesh Vijayanarayanan (Vijay), Evodental specializes in surgically implanting a full set of teeth in a day using its on-site laboratory.
The company currently has a client list of over 500 and employs 10 staff.. .
Genomes.io also offers the gold standard in genomic data protection. Using state-of-the art encryption and blockchain technologies, no one except you can view or access your data without your consent.
DNA data is shared anonymously and can never be viewed in plain text.. .
Ixico is a U.K.-based company that provides clinical trial services worldwide. The company offers end-to-end imaging services in various therapeutic areas, primarily in the fields of oncology and neurology to the pharmaceutical industry, biotech companies, academia, and medical charities.
Ixico offers technology developing solutions for the treatment of diseases, including predominantly dementia and other neuro degeneration diseases. It is based in London, England..
Istesso is a drug discovery and development company working in the field of immunometabolism. Our pipeline of pre-clinical and clinical assets act by reprogramming metabolism to treat autoimmune and inflammatory conditions such as rheumatoid arthritis and multiple sclerosis.
Istesso was founded in 2017 as the holding company for Modern Biosciences Ltd.. Guinness World Records also annually publishes the Gamerâ€™s Edition; a records book devoted solely to the world of computer gaming and high score record achievements.
The Guinness World Records website receives more than 11 million visitors a year. Guinness World Records is part of the Jim Pattison Group, one of Canadaâ€™s largest privately owned companies which is a conglomerate of interests, including entertainment, advertising, broadcasting, grocery stores and automotive retailing..
Sixfold Bioscience is a preclinical-stage biotech company that engineers targeted therapeutic delivery systems. Their programmable oligonucleotide delivery systems are able to deliver gene therapy molecules exclusively to diseased cells.
It also provides a solution to the drug delivery challenge, bringing cures for genetically-driven diseases to patients. Sixfold Bioscience was founded on 2017 and is headquartered in London..
By combining real-time bidding technology and premium advertisers from around the world, Avocarrot is an all-in-one platform for optimizing and monitoring native ad revenue.. .
MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a patient’s bloodstream. MBF is an extracorporeal technology, similar to dialysis.
A patient’s blood is continuously circulated through an external blood loop containing the MediSieve system. Targeted magnetic particles (TB-MPs) are infused into the loop, binding specifically to disease-relevant targets in the patient’s blood.
The blood then flows through a magnetic filter which captures the particles and bound targets and the remainder of the blood returns to the patient unaffected; the TB-MPs never enter the patient’s body. MediSieve is based at the Imperial Incubator in White City, London.
It has dedicated workshop and laboratory facilities (including capacity for ELISAs, Flow Cytometry and human blood testing) in which products are developed and validated.. .
Engitix is using its proprietary human organ decellularisation technology to develop tissue engineered products for application in regenerative medicine and drug-target research. Engitix’ core expertise is treatment and research of liver disease using its proprietary technologies for human extra-cellular matrix (ECM) scaffolds and 3D spheroids for bioartificial liver devices.
The scaffold technology is applicable to other organs and disease aetiologies including pancreatic and intestine scaffold products.. .
Brightcure is solving the lack of treatment options available for patients suffering from recurrent urinary tract infections (UTIs). UTIs are one of world’s most common infections, affecting 50% of women and 12% of men worldwide.
Current UTI treatments are not effective, can cause serious side effects, and often accelerate antibiotic-resistant infections. Total UTI costs currently amount over $ 8.6B per year.
With UTI bacteria becoming increasingly difficult to treat, the size of the UTI market is expected to reach $ 12.41B by 2025. Brightcure utilizes the natural microbiome to reduce harmful bacteria and replenish the good bacteria in the vaginal flora.
Brightcure’s bioactive intimate cream boosts the natural immune system to promote a healthy urinary tract. BrightCure was founded in 2019 and is headquartered in London, England.
In 2020, BrightCure got a seed investment from SOSV and was selected as 1 out of 9 companies to be part of the world’s largest biotech accelerator, Indiebio, to develop its first product. BrightCure has been selected as one of the Top 7 companies of the McKinsey Venture Challenge, Top 5 of the Mayor of London Competition, has won Imperial College’s White City Innovation Program, and has taken part in the finals of ‘The Pitch’ London Competition being selected among 850 other applications..
Intoolab is an Artificial Intelligence company, focused on Bayesian Inference, with the main product being Tzager the “Tensorflow” of Bayesian Networks. Tzager is the first Bayesian Inference A.I.
framework in python, built for biomedical research, drug discovery, and personalized medicine with the main features being Biochemical Analysis, Predictor Research/Models, and Literature Review/Management. Tzager is not just another deep learning algorithm trained to solve very specific problems, but an intelligence system with its own framework based on Causal Equations and Bayesian Networks.
Tzager has created its understanding of how the human body works by emulating how we humans understand Biomedicine through causal reasoning and experience, powered by its Healthcare Bayesian Network.. .
MyMeds&Me Ltd was formed in 2011 by Dr Andrew Rut, Dr Trevor Gibbs and Steve Powell. The founders bring together a unique blend of pharmaceutical and commercial experience, encompassing leadership of global clinical development, safety & pharmacovigilance operations, and the development and global commercialization of technology solutions for the life sciences industry.
The strength of this leadership and the business case to create an industry-wide technology solution, led to significant funding being obtained from within the pharmaceutical industry itself and private equity during 2012/13.. .
Our platform is based on the principals of empowerment, equality, accountability, transparency and ethical business practices. Features Free Live Streams, Premium Group Live Streams, Premium 1-2-1 Live Streams, Search Feature.
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) is a pharmaceutical company dedicated to the discovery, development and commercializing of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers (including orphan oncology indications). The pipeline of Aptorum is also enriched through the establishment of drug discovery platforms that enable the discovery of new therapeutics assets through, e.g.
systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. In addition to the above main focus, it is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women’s health and other disease areas.
It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms.. Unibuddy was founded in 2015 and is headquartered in London, England, UK..
Arborea is a biochemical technology company that develops an organic cultivation system for sustainable healthy food ingredients. Its biological and chemical engineering technology platforms helps produce numerous sustainable and healthy food ingredients such as antioxidants, functional proteins, lipids, polysaccharides, and many more.
The company propriety technology, the BioSolar Leaf, enables industrial-scale algae biоmass prоduction with lower оperational and capital cоsts, unlimited scalability, and higher yields compared to current algae cultivation technolоgies based on photо-bioreactоrs (PBR) and оpen pоnds. It is able tо generate breathable оxygen, to decrease building’s climatic contrоl energy consumption, to fix CO2 and to remоve air pollutants.
Arborea was founded in 2015 and is based in London.. We provide a universal, customisable lead capture solution for use at every event, big or small, and seamlessly integrated back into existing systems.
The result? A streamlined Event Qualified Lead capture process from the show-floor to an automated, personalised and timely follow up, enabling our customers to truly maximise the success of their exhibition strategy. Our growing customer base spans across a wide range of sectors including the likes of IBM, Aston Martin, Sony, Promega, PayPal and LogRhythm..
Feed Algae Ltd. is on the road to becoming the world’s lowest cost producer of algal biomass and thereby enable us all to fully harness for the first time the fastest growing, highest yielding, most nutritious, most carbon-absorbing organism on the planet.
We have licensed patented technology that gives us the means to recreate the natural growing conditions of algae that have made them the most successful organism on the planet. The technology itself is remarkably simple, combining leading edge knowledge of how algae behave with tried and tested, large scale pond engineering.
This bio-industry will produce product for chemicals, fuel, feed and other uses.. _Decreasing Churn_ We help your subscribers get the most from their devices with award-winning news utilities that offer frictionless access to engaging content.
As such, we are able to dramatically increase network usage and decrease churn. We do not believe that one size fits all.
We adopt a fully – integrated approach to ensure a product-market – fit by working with our partners to understand their subscribers from day one, integrating data sets and determining which technologies are most appropriate for each device type, usage habits and demographic.. .
ExcepGen is the only company able to produce a large number of complex human proteins quickly. Pharmaceutical companies need these proteins for drug development, and every ExcepGen protein can save them months of development time and millions in costs; the protein could also prevent multi-billion dollar drug failures caused by inaccurate hit identification.
Today, ExcepGen is working with 3 of the top 15 pharmaceutical companies.. .
Quell’s vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.
Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cell engineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader “Immune tolerance” in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.. Fire Tech’s mission is to be the go-to resource for families who are preparing for the future – by offering courses in digital skills, helping young people develop other 21st century skills like communication, collaboration, creativity and critical thinking.
We’ll also be a resource to parents who need help to support their kids as they grow into the digital future, and are looking for how to best understand what their children will need, and learn together.. .
Valirx Plc, an investment holding company, engages in the research and development of oncology therapeutics and diagnostics in the United Kingdom. The company principally offers VAL 101 that acts to shut down the Bcl-2 gene, a proto-oncogene.
It develops human papilloma virus diagnostic products based on the Nucleosomics, a platform for non-invasive tests for early cancer diagnosis based on epigenetic signal changes associated with malignancy; and HyperGenomics, a platform for differential diagnostic and prognostic tests in cancer, as well as testing for personalized medicine. The company also develops GeneICE compounds, which treat various diseases by acting to shut down harmful genes and prevent their expression.
Valirx Plc is based in London, the United Kingdom.. .
Kesios Therapeutics Limited develops small molecule drugs for haematological malignancies, such as multiple myeloma and related indications. The company was incorporated in 2012 and is based in London, United Kingdom..
How a brand, its products and people are represented inside search engines impacts a businesses’ ability to compete. Linkdex’s ability to unite the SEO, PR, Social, and Content functions in enterprise businesses is critical because managing search engines is no longer solely an SEO’s job.
Search is part of a wider marketing play that offers huge rewards for brands with insight driven strategies, engaged teams and optimal investment. Linkdex brings all of these areas together in one platform.
Breaking down the data silos, providing award winning insights and helping teams work together towards common goals. Linkdex is the winner of: UK Search Awards – Best SEO Software Award Winner 2013 US Search Awards – Best SEO Software Award Winner 2013 European Search Awards – Innovation Award Winner 2013.
A marketplace for continual growth and the global authority for AQ.. .
Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well as safe and effective TCRs against these tumour targets for therapeutic application.
Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.. .
Acellera is a company devoted to speed up drug discovery and development. Acellera is focused on delivering services and solutions to companies and academic institutions on computing intensive, mission critical applications.
By exploiting heavy optimization techniques and the outstanding computational capabilities of new accelerator processors, they help to achieve performances which would be otherwise unreachable using current standard technology. Acellera is a company with more than 10 years of experience speeding up drug discovery and development with computer assisted methods..
TopiVert is a clinical-stage biotechnology company developing next-generation, Narrow Spectrum Kinase Inhibitors (NSKIs) as novel, non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal (GI) tract and the eye. The lead GI programme TOP1288 is currently in a Phase IIa proof of concept study in ulcerative colitis.
A Phase I/II study with TOP1630 for dry eye syndrome will commence in the US in early 2017.. All work is backed up and synced to the cloud, so students can access, collaborate, and add to projects anywhere, on any device..
Syncona Partners LLP
Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
They seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. They take a long-term view, underpinned by a deep pool of capital, and are established leaders in the development of genetic medicine, particularly gene and cell therapy.
They focus on delivering dramatic efficacy for patients in areas of high unmet need. Syncona is aligned with two of the premium charitable funders in UK science, The Wellcome Trust, original founder of Syncona, and Cancer Research UK, both of which are significant shareholders in their business.
They make a donation of 0.3% of Net Asset Value to a range of charities each year.. .
ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV. Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and new HIV medicines as well as support communities affected by HIV..
It validates the purchase in real time based on a photo of the receipt submitted by shoppers. Shopitize directly rewards the shopper with either cash transmitted to bank account or via PayPal, or through cost effective non-monetary rewards such as vouchers, points or other reward types via reward partners.
Shopitize automatically collects and analyses all data on receipts across multiple retailers and dynamically segments and targets shoppers by their behavioural profiles so that it may structure personally relevant deals to them. Shopitize provides brands and retailers a smarter and a more cost-efficient way of delivering traditional and proven marketing tactics and mechanics such as supporting product launches, product promotions, sampling campaigns, sweepstakes, ‘Buy 1, Get 1 For Free’, competitions, customer surveys and loyalty programmes.
The products and solutions are either supporting short-term one-off campaigns, or are based on a long-term integrated partnership with the customer.. .
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. operates as an immuno-oncology company.
Founded in February 2015 by Professor Cerundolo, iOx Therapeutics is a spin-out from the University of Oxford started to commercialize discoveries made as part of a long-running collaboration between Oxford and the Ludwig Institute for Cancer Research. iOx intends to develop and commercialize multiple synthetic lipid compounds discovered by a research team led by Professor Cerundolo..
It was founded by Brian Wiegand, Mark Mcguire, and Rob Pierre in 2005.. .
Biotronics3D, headquartered in London, England, develops and markets innovative software applications for the diagnostic imaging industry. They provide cutting edge software technologies to improve healthcare by better extracting diagnostic data and transforming it into usable information available at the point-of-care.
Biotronics3D Ltd is an EN ISO 13485:2003 certified company. Their flagship product, 3Dnet Enterprise Suite, has received FDA 510K market clearance and it is CE marked..
Stabilitech is a privately held company focused on stabilisation of sensitive biological molecules, such as vaccines and biopharmaceuticals. The company was founded by Dr Jeff Drew, and started research operations in 2004.
Stabilitech is based at the London Bioscience Innovation Centre, London UK. Stabilitech’s goal is to improve the stability of vaccines and biopharmaceuticals using their proprietary formulation technology.
Stabilitech’s technology permits the long-term stabilisation of a wide range of thermally sensitive viruses, vaccines and biopharmaceuticals. Excipient compositions contain only chemical ingredients already used in clinical settings, approved injectables or on the Generally Regarded As Safe (GRAS) list.
Their business model is to establish partnerships with major pharmaceutical and biotechnology companies, as well as with global health organisations, to commercialise their technology.. Get in touch with us: [email protected]
You may write to us at: BestStartup.co.uk/Fupping Ltd, 349 Royal College Street, London, England, NW1 9QS.